BIOLASE Inc Stock Nasdaq
Equities
US0909111082
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 51.5M | Sales 2025 * | 55.5M | Capitalization | 4.79M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.09 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.45
x | P/E ratio 2025 * |
-1.31
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on BIOLASE Inc
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director of Finance/CFO | 53 | 21-01-31 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 14-07-31 |
John Beaver
CEO | Chief Executive Officer | 62 | 17-09-30 |
Director/Board Member | 73 | 21-08-15 |
1st Jan change | Capi. | |
---|---|---|
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
+16.21% | 52.82B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B |